ARTICLE
16 August 2017

Healthcare Legislation Outlook And Update

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
In this memorandum, Holland & Knight's Healthcare & Life Sciences Team summarizes recent U.S. Senate action on healthcare legislation and provides an outlook on upcoming issues and possible actions.
United States Food, Drugs, Healthcare, Life Sciences
Holland & Knight are most popular:
  • within Strategy topic(s)

Robert Bradner is a Partner in our Washington D.C. office. Lisa Tofil is a Partner in our Washington D.C. office. Nicole M. Elliott is a Partner in our Washington D.C. office. Miranda A. Franco is a Senior Policy Advisor in our Washington D.C. office.

In this memorandum, Holland & Knight's Healthcare & Life Sciences Team summarizes recent U.S. Senate action on healthcare legislation and provides an outlook on upcoming issues and possible actions.

Holland & Knight will follow up as developments warrant, in particular with regard to a possible announcement on cost-sharing reduction subsidies.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More